Natural products have been considered the primary source of healthcare among the majority of the world’s population. In the therapeutic management of Covid-19, products of natural origin are a promising and potential medicinal source to treat this disease. Our research methodology is based on a review of recent articles reporting on the effect of medicinal plants on Covid-19. In this review, literature searches on medicinal plants which used to treat and prevent Covid-19 disease were conducted. From this research, several medicinal plants have received much research attention such as Astragalus mongholicus Bunge; Astragalus membranaceus (Fisch.) Bunge; Atractylodes lancea (Thunb.) DC.; Atractylodes chinensis (DC.) Koidz.; Atractylodes japonica Koidz.; and Atractylodes macrocephala Koidz.; Andrographis paniculata; Lonicera japonica; Scutellaria baicalensis Georgi. However, the definitive roles of these medicinal plants in cytokine storms and post-infection complications still need further investigation. And then, quality control and standardisation of medicinal plants-based products also need to be emphasized. Further investigations on differential effects as well as the quality and safety of herbal medicines should be required to ascertain their role in Covid-19 therapeutic management. Furthermore, herbal mixtures, medicinal plants, natural products, or their combination with possible anti-SARS-CoV-2 effects may hold promise and effectiveness in preventive and therapeutic support for Covid-19.